ARCHIVES

Phase III Study: Rituxan Improved PFS By 79% In Advanced Follicular Lymphoma

This article is from The Cancer Letter archive.

Vol. 33 No. 12 | December 31, 2010

Download PDF Visit The Full Archive

Related Articles

National Cancer Policy Board a Successful Experiment, NCI Says; Funding Extended

May 19, 2000

Greenwald Lists Items Missing Because Not Enough Money Available

November 25, 1988

Cancer Genome Atlas Researchers Link Cell Metabolism Pathways To Disease Aggressiveness

July 26, 2013

Risk of Lymphoma Increases with Hepatitis C Virus Infection

May 25, 2007

Healy Attacks Scripps-Sandoz Research Deal, Rep. Wyden Asks For HHS Investigation

March 19, 1993

Pittsburgh Broadens Inquiry To Include Lawrence Wickerham

July 15, 1994